Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model

Journal of Bone and Mineral Metabolism

Volumn 31, Issue 1, 2013, Pages 16-25

  Ezaki, Junko ^a   Hashimoto, Miyuki ^a,b   Hosokawa, Yu ^b   Ishimi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b JISSEN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cartilage; Health food; Inflammation; Sulfur compound

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CHOLESTEROL; DIMETHYL SULFONE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATROPHY; BODY FAT; BODY WEIGHT; BONE DENSITY; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FOOD INTAKE; KNEE OSTEOARTHRITIS; LEAN BODY WEIGHT; LIVER INJURY; LIVER WEIGHT; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN WEIGHT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARTILAGE; DIMETHYL SULFOXIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; KNEE JOINT; MALE; MICE; OSTEOARTHRITIS, KNEE; RATS; SULFONES;

EID: 84876289642     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-012-0378-9     Document Type: Article

References (34)

1. Pearson TW, Dawson HJ, Lackey HB (1981) Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains, and beverages. J Agric Food Chem 29:1089-1091
2. Williams KI, Burstein SH, Layne DS (1966) Dimethyl sulfone: isolation from human urine. Arch Biochem Biophys 113:251-252
3. Parcell S (2002) Sulfur in human nutrition and applications in medicine. Altern Med Rev 7:22-44
4. (2003) Natural Medicines Comprehensive Database, 5th edn. Therapeutic Research Faculty
5. Rose SE, Chalk JB, Galloway GJ, Doddrell DM (2000) Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Imaging 18:95-98
6. Lin A, Nguy CH, Shic F, Ross BD (2001) Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett 123:169-177
7. Cecil KM, Lin A, Ross BD, Egelhoff JC (2002) Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementation. J Comput Assist Tomogr 26:818-820
8. Engelke UF, Tangerman A, Willemsen MA, Moskau D, Loss S, Mudd SH, Wevers RA (2005) Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed 18:331-336
9. McCabe D, O'Dwyer P, Sickle-Santanello B, Woltering E, Abou-Issa H, James A (1986) Polar solvents in the chemoprevention of dimethylbenzanthracene- induced rat mammary cancer. Arch Surg 121:1455-1459
10. O'Dwyer PJ, McCabe DP, Sickle-Santanello BJ, Woltering EA, Clausen K, Martin EW Jr (1988) Use of polar solvents in chemoprevention of 1, 2-dimethylhydrazine-induced colon cancer. Cancer (Phila) 62:944-948
11. Ebisuzaki K (1988) Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res 23:453-458
12. Alam SS, Layman DL (1983) Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann N Y Acad Sci 411:318-320
13. Beilke MA, Collins-Lech C, Sohnle PG (1987) Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med 110:91-96
14. Layman DL (1987) Growth inhibitory effects of dimethyl sulfoxide and dimethyl sulfone on vascular smooth muscle and endothelial cells in vitro. In Vitro Cell Dev Biol 23:422-428
15. Morton JI, Siegel BV (1986) Effects of oral dimethyl sulfoxide and dimethyl sulfone on murine autoimmune lymphoproliferative disease. Proc Soc Exp Biol Med 183:227-230
16. Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN (2002) A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. J Altern Complement Med 8:167-173
17. Akesson K (1999) Osteoarthritis and degenerative spine pathologies. In: Seibel MJ, Robins SP, Bilezikian JP (eds) Dynamics of bone and cartilage metabolism. Academic Press, London, pp 637-648
18. Rizzo R, Grandolfo M, Godeas C, Jones KW, Vittur F (1995) Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) study. J Exp Zool 273:82-86
19. Murav'ev IuV, Venikova MS, Pleskovskaia GN, Riazantseva TA, IaA Sigidin (1991) Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patol Fiziol Eksp Ter 2:37-39
20. Hasegawa T, Ueno S, Kumamoto S, Yoshikai Y (2004) Suppressive effect of methylsulfonylmethane (MSM) on type II collagen-induced arthritis in DBA/1 J mice (in Japanese). Yakuri To Chiryo (Jpn Pharmacol Ther) 32:421-427
21. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
22. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, Suda T (1997) Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 94:9360-9365
23. Gimblet EG, Marney AF, Bonsnes RW (1967) Determination of calcium and magnesium in serum, urine, diet, and stool by atomic absorption spectrophotometry. Clin Chem 13:204-214
24. Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523-537
25. McAlindon TE, LaValley MP, Gulin JP, Felson DT (2000) Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 283:1469-1475
26. Usha PR, Naidu MUR (2004) Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Invest 24:353-363
27. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF (2006) Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthr Cartil 14:286-294
28. Brien S, Prescott P, Bashir N, Lewith H, Lewith G (2008) Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthr Cartil 16:1277-1288
29. Brien S, Prescott P, Lewith G (2009) Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evid Based Complement Alternat Med 2011(528403):12
30. Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, Elbaz A, Beer Y, Debi R (2011) Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Alternat Med 11:50
31. Mason RM, Chambers MG, Flannelly J, Gaffen JD, Dudhia J, Bayliss MT (2001) The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthr Cartil 9:85-91
32. Richmond VL (1986) Incorporation of methylsulfonylmethane sulfur into guinea pig serum proteins. Life Sci 39:263-268
33. Horvath K, Noker PE, Somfai-Relle S, Glavits R, Financsek I, Schauss AG (2002) Toxicity of methylsulfonylmethane in rats. Food Chem Toxicol 40:1459-1462
34. Magnuson BA, Appleton J, Ryan B, Matulka RA (2007) Oral developmental toxicity study of methylsulfonylmethane in rats. Food Chem Toxicol 45:977-984